pubh chapter 2

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/59

encourage image

There's no tags or description

Looks like no tags are added yet.

60 Terms

1
New cards

perie: problem, etiology, recommendations, implementation, evaluation

five steps in utilizing an evidence based approach to public health practice

2
New cards

problem

describing the health problem by assessing its burden (frequency, distribution, and severity), course (natural history), and who/where/when it affects a population

3
New cards

etiology

identifying the underlying causes and risk factors (the why/how) of the disease by evaluating group associations and establishing contributory cause

4
New cards

recommendations

determining what works to reduce or eliminate the health problem based on evidence of effectiveness, efficacy, and safety of potential interventions

5
New cards

implementation

putting the recommended interventions into practice by deciding how to implement them (e.g. target populations, timing, levels of prevention)

6
New cards

evaluation

assessing the real world impact and effectiveness of the implemented program or policy to determine if it achieved the desired goals and whether modifications are required

7
New cards

mortality

the occurrence of death due to a disease or health condition within a population

8
New cards

morbidity

the occurrence of illness, disability, or impairment due to a health condition (non-fatal health outcomes)

9
New cards

burden of disease

the comprehensive impact of a health problem in a population, combining frequency, distribution, and severity through both morbidity and mortality

10
New cards

descriptive epidemiology

enumerate, quantify, and summarize health patterns to generate hypotheses regarding potential causes or risk factors

11
New cards

analytic epidemiology

test and evaluate specific hypotheses to establish cause and effect relationships (etiology) between exposures and outcomes

12
New cards

distribution (who/where/when)

focus of descriptive epidemiology

13
New cards

determinants (why/how)

focus of analytic epidemiology

14
New cards

case reports, case series, cross-sectional studies, ecological studies

kinds of descriptive epidemiology study designs

15
New cards

observational cohort, case-control studies, experimental cohort (clinical/community trials)

kinds of analytic epidemiology designs

16
New cards

rate

measures how rapidly a health event occurs in a defined population over a specified time unit

17
New cards

risk

measures the probability/likelihood that an individual will develop a disease or experience a health outcome over a specific period

18
New cards

incidence

measures the occurrence of NEW cases developing in a population initially free of the disease during a specified period; best for studying causes/risk factors

19
New cards

prevalence

measures the proportion of all EXISTING cases (both new and old) present in a population at a specific point/period of time; best for planning healthcare services

20
New cards

health events of interest during period / population at risk of event during period


rate formula

21
New cards

new cases during period / population at risk at start

cumulative incidence rate formula

22
New cards

new and old cases at a point / total population at that point

point prevalence rate formula

23
New cards

new and old cases during period / total population during period

period prevalence rate formula

24
New cards

exposed incidence rate - unexposed incidence rate

attributable risk formula

25
New cards

exposed incidence rate / unexposed incidence rate

relative risk formula

26
New cards

deaths / number of persons who could die x 10n

mortality rate formula

27
New cards

mortality rate

measure of total deaths in a population over a given time frame

28
New cards

infant deaths / live births x 1000

infant mortality rate formula

29
New cards

infant mortality rate

quantifies deaths occurring among infants (under 1 year) relative to live births

30
New cards

case reports, case series, cross-sectional study, ecological study, observational/experimental cohorts, case control

types of epidemiology studies

31
New cards

case report

detailed clinical description of single unusual cases/identifying the range of experiences

32
New cards

case series

detailed clinical description of small clusters of cases/identifying trends or patterns across health events

33
New cards

cross-sectional study

surveys that assess exposure and disease outcome simultaneously at a single point in time across individuals/associations among variables

34
New cards

ecological study

analyzes aggregate or group-level data rather than individual level data

35
New cards

ecological fallacy

mistakenly inferring that group-level associations apply to individual human beings

36
New cards

identify new disease, rare conditions, clinical patterns

purpose of case reports and case series

37
New cards

snapshot associations between variables across individual characteristics

purpose of cross-sectional studies

38
New cards

examine population level exposure-disease correlations quick and cheap

purpose of ecological studies

39
New cards

observational cohort, experimental cohort, case control

types of analytic epidemiology studies

40
New cards

concurrent, historical

types of observational cohort studies

41
New cards

clinical trials, community trials

types of experimental cohort studies

42
New cards

observational cohort

groups are categorized by their exposure status (exposed or not) and followed forward or through records over time to see who develops outcome (calculates relative risk)

43
New cards

concurrent cohort

follows participants into the future

44
New cards

historical cohort

uses past medical/exposure records as a cohort

45
New cards

case control study

groups are selected based on their disease status (with disease vs. control, without disease) and researchers look backward to compare prior exposure histories (calculates odds ratios)

46
New cards

experimental cohort

researchers actively assign exposure/intervention status (e.g. treatment vs. placebo) to participants, ideally blind and random

47
New cards

clinical trials

experimental cohort study on individuals

48
New cards

community trials

experimental cohort study on entire communities, schools, etc.

49
New cards

temporal relationship, strength of association, dose-response relationship, consistency of association, biological plausibility, reversibility/cessation of exposure

criteria to establish a contributory cause

50
New cards

temporal relationship

the exposure MUST come before the outcome in time

51
New cards

strength of association

stronger associations (e.g. RR, OR) make it more likely that the relationship is causal rather than due to confounding

52
New cards

dose-response relationship

increase exposure levels (e.g. higher dose, frequency, or duration) correspond to increased risk or severity of the outcome

53
New cards

consistency of association

similar associations are repeatedly observed across different populations, locations, study designs, and times

54
New cards

biological plausibility

the observed association is consistent with existing scientific, biological, and medical knowledge

55
New cards

reversibility/cessation of exposure

removing or reducing the exposure leads to a reduction in the risk of disease

56
New cards

primordial prevention

aims to avoid the emergence and establishment of social, economic, and environmental patterns of living that contribute to elevated disease risk

57
New cards

primary prevention

prevents disease or injury BEFORE it occurs by targeting susceptibility and eliminating exposures/risk factors (e.g. vaccines, fluoridated water, smoking ban)

58
New cards

secondary prevention

catches disease in its early, subclinical stages through early detection and prompt screening to halt progression (e.g. mammograms, pap smears)

59
New cards

tertiary prevention

manages established clinical disease to prevent further disability, severe complications, or premature death and restore function (e.g. administering tPA clot-busting drug during active stroke, stroke rehab)

60
New cards

exposed odds of outcome / unexposed odds of outcome

odds ratio formula